About Index Trending news
Analyze
Top 50 Pricing
miRagen Therapeutics

miRagen Therapeutics

Work at miRagen Therapeutics? Add yourself to this profile

miRagen Therapeutics

miRagen is a clinical stage biopharmaceutical company developing innovative microRNA-targeting therapies to improve human health.

Elsewhere

Alexa global traffic share

Twitter followers

Latest funding Show all
Venture capital (Series D)
$40,000,000
Atlas Venture, MP Healthcare Venture Management, Fidelity Management and Research Company, +4
Venture capital (Series C)
$8,500,000
Atlas Venture, Boulder Ventures, Broadview Ventures, +2
Employees

Team size

10+
Locations
HQ
$40,000,000 Venture capital (Series D)
PE HUB

Miragen racks up $40 mln, will merge with Signal Genetics